Store besparelser
Hurtig levering
Gemte
Log ind
0
Kurv
Kurv
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Engelsk Paperback
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Engelsk Paperback

811 kr
Tilføj til kurv
Sikker betaling
6 - 8 hverdage

Om denne bog

This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs. 

Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compounds currently under evaluation.

Product detaljer
Sprog:
Engelsk
Sider:
300
ISBN-13:
9782817805573
Indbinding:
Paperback
Udgave:
ISBN-10:
2817805577
Udg. Dato:
23 aug 2016
Længde:
0mm
Bredde:
155mm
Højde:
235mm
Forlag:
Springer Editions
Oplagsdato:
23 aug 2016
Forfatter(e):
Kategori sammenhænge